✕
☰

Top 5 collaborations tackling cancer

by

Pharma companies have been teaming up in the fight against cancer. EPM lists the top 5 cancer fighting collaborations

Biocartis and Merck

Biocartis has signed a collaboration agreement with Merck for the development and commercialisation of a new liquid biopsy RAS biomarker test for patients with metastatic colorectal cancer (mCRC).

To find out more, click here.

Sanofi and Warp Drive Bio

Sanofi are collaborating with Warp Drive Bio, a privately held biotechnology company, to discover novel oncology therapeutics and antibiotics using Warp Drive's proprietary SMART (Small Molecule Assisted Receptor Targeting) and Genome Mining platforms.

To find out more, click here.

Debiopharm and EORTC

Debiopharm International is collaborating with the European Organisation for Research and Treatment of Cancer (EORTC) in order to supply triptorelin pamoate for salivary gland cancer

To find out more, click here.

MyTomorrows and Spectrum Pharmaceuticals

MyTomorrows and Spectrum Pharmaceuticals have teamed up to provide access to liposome-encapsulated vincristine for the treatment of Philadelphia chromosome negative acute lymphoblastic leukaemia.

To find out more, click here.

Kymab and MD Anderson ORBIT

The University of Texas MD Andersons Oncology Research for Biologics and Immunotherapy Translation (ORBIT) is collaborating with Kymab to discover and develop novel human therapeutic antibodies to treat a variety of cancers.

The collaboration is focusing on the development of novel monoclonal antibodies as well as identifying biomarkers for identification of responder populations.

To find out more, click here.

Back to topbutton